Skip to main content
. 2018 Aug 14;18:104. doi: 10.1186/s12871-018-0572-y

Table 1.

Demographic data, baseline characteristics, and patient outcomes. Data are presented as mean (standard deviation), median (quartiles), and frequency (%)

Control group (n = 21) Dexmedetomidine group (n = 21) P value
Age (years) 32 (5)a 29 (4) 0.05
BMI (kg/m2) 45 (3)a 48 (4) 0.03
Smoking 5 (25%) 6 (29%) 0.95
COPD, emphysema 0(%) 0 (0%) 1
FVC (% predicted) 65 (61,67) 62 (60,66) 0.28
FEV1/FVC (%) 81 (78,84) 80 (77,83) 0.33
Baseline PaCO2 (mmHg) 42 (7) 39 (5) 0.1
Surgical duration 113 (19) 109 (18) 0.5
Intraoperative fluids 844 (101) 831 (103) 0.7
Blood loss 238 (76) 258 (78) 0.4
Postoperative complications
 - ICU admission 3 (14%) 2 (10%) 0.9
 - Invasive ventilation 2 (10%) 1 (5%) 1
 - Anastomotic leakage 0 (0%) 0 (0%) 1
 - Bleeding 0 (0%) 0 (0%) 1
 - Pneumonia 0 (0%) 0 (0%) 1
 - 28-day death 0 (0%) 0 (0%) 1
POSS 2 (1,2) 2 (1,2) 1

BMI Body mass index, COPD Chronic obstructive pulmonary disease, FEV1 Forced expiratory volume in the first second, FVC Forced vital capacity, ICU intensive care unit, POSS Pasero opioid-induced sedation scale, P/F ratio PaO2/fraction of inspired oxygen

adenotes statistical significance between both groups